Cannabis Domino Effects in the EU: When Will the Framework Decision Start to Falter? And what happens in Switzerland?
SpeakerLaura RamosCannaReporter®ModeratorSimone van BredaUnion of Coffeeshop RetailersDaniel HaymannMME Legal | Tax | ComplianceSita SchubertEUMCA
Recreational Cannabis masquerading as Medical, and the E-Commercification of Prescription Medicine in Europe
SpeakerDaniel HaymannMME Legal | Tax | ComplianceModeratorKai-Friedrich NiermannKFN+ Law OfficeModeratorRobert JappieFieldfisher LLPMarie SanchezNOOA AvocatsKaeli ZimmermannKaeli Zimmermann Consulting
Mögliche Änderung des MedCanG: Kommen neue Zeiten auf uns zu? Auswirkungen auf Versorgung, Markt und Stakeholder
SpeakerLarissa MößmerOsborne ClarkeBijan Christoph HezarkhaniBCHModeratorThomas HaukLinnaeus PartnersChristiane NeubaurVerband der Cannabis versorgenden Apotheken (VCA)
Beyond stigma: The CanG Evaluation – The Key to Data- and Evidence-Based Cannabis Regulation?
SpeakerMoritz Försterkrautinvest.de
The CanG Evaluation: The Starting Point of a Fact-Based Policy Era?
SpeakerMoritz Försterkrautinvest.deModeratorDirk HeitepriemBranchenverband Cannabiswirtschaft eV (BvCW)Daniel S. HübnerLinnaeus Partners UGBernd WerseFrankfurt University of Applied SciencesAntonia MenzelSanity Group
An Overview of the French Cannabis Market: Current Realities and Regulatory Challenges
SpeakerPaul MacleanUnion des Professionnels du Cannabis Bien-être et Détente (UPCDB)
Global regulatory developments and the impact on the cannabis industry
SpeakerBertan TüremisSanity GroupDirk HeitepriemBranchenverband Cannabiswirtschaft eV (BvCW)
